[Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma]
- PMID: 27546508
[Glutamate receptor-mediated retinal neuronal injury in experimental glaucoma]
Abstract
Glaucoma, the second leading cause of blindness, is a neurodegenerative disease characterized by optic nerve degeneration related to apoptotic death of retinal ganglion cells (RGCs). In the pathogenesis of RGC death following the onset of glaucoma, functional changes of glutamate receptors are commonly regarded as important risk factors. During the past several years, we have explored the mechanisms underlying RGC apoptosis and retinal Müller cell reactivation (gliosis) in a rat chronic ocular hypertension (COH) model. We demonstrated that elevated intraocular pressure in COH rats may induce changes of various signaling pathways, which are involved in RGC apoptosis by modulating glutamate NMDA and AMPA receptors. Moreover, we also demonstrated that over-activation of group I metabotropic glutamate receptors (mGluR I) by excessive extracellular glutamate in COH rats could contribute to Müller cell gliosis by suppressing Kir4.1 channels. In this review, incorporating our results, we discuss glutamate receptor- mediated RGC apoptosis and Müller cell gliosis in experimental glaucoma.
Similar articles
-
TRPV4-induced Müller cell gliosis and TNF-α elevation-mediated retinal ganglion cell apoptosis in glaucomatous rats via JAK2/STAT3/NF-κB pathway.J Neuroinflammation. 2021 Nov 17;18(1):271. doi: 10.1186/s12974-021-02315-8. J Neuroinflammation. 2021. PMID: 34789280 Free PMC article.
-
Involvement of P2X7 receptors in retinal ganglion cell apoptosis induced by activated Müller cells.Exp Eye Res. 2016 Dec;153:42-50. doi: 10.1016/j.exer.2016.10.005. Epub 2016 Oct 6. Exp Eye Res. 2016. PMID: 27720859
-
Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model.Neuropharmacology. 2020 Jun 15;170:108016. doi: 10.1016/j.neuropharm.2020.108016. Epub 2020 Feb 23. Neuropharmacology. 2020. PMID: 32101763
-
Activation of retinal glial cells contributes to the degeneration of ganglion cells in experimental glaucoma.Prog Retin Eye Res. 2023 Mar;93:101169. doi: 10.1016/j.preteyeres.2023.101169. Epub 2023 Feb 1. Prog Retin Eye Res. 2023. PMID: 36736070 Review.
-
Understanding glaucomatous damage: anatomical and functional data from ocular hypertensive rodent retinas.Prog Retin Eye Res. 2012 Jan;31(1):1-27. doi: 10.1016/j.preteyeres.2011.08.001. Epub 2011 Sep 21. Prog Retin Eye Res. 2012. PMID: 21946033 Review.
Cited by
-
CCR1 mediates Müller cell activation and photoreceptor cell death in macular and retinal degeneration.Elife. 2023 Oct 30;12:e81208. doi: 10.7554/eLife.81208. Elife. 2023. PMID: 37903056 Free PMC article.
-
Kir4.1 may represent a novel therapeutic target for diabetic retinopathy (Review).Exp Ther Med. 2021 Sep;22(3):1021. doi: 10.3892/etm.2021.10453. Epub 2021 Jul 15. Exp Ther Med. 2021. PMID: 34373707 Free PMC article. Review.
-
Overexpression of the inwardly rectifying potassium channel Kir4.1 or Kir4.1 Tyr 9 Asp in Müller cells exerts neuroprotective effects in an experimental glaucoma model.Neural Regen Res. 2026 Apr 1;21(4):1628-1640. doi: 10.4103/NRR.NRR-D-24-00461. Epub 2024 Nov 13. Neural Regen Res. 2026. PMID: 39589165 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous